Neeta Somaiah, MD (she/her/hers)
Associate Professor and Deputy Chair
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Michael C. Heinrich, MD
Professor of Medicine
Portland VA Health Care System and Oregon Health & Science University Knight Cancer Institute
Portland, Oregon, United States
Jonathan Trent, MD, PhD
Professor of Medicine
Sylvester Comprehensive Cancer Center, University of Miami
Miami, Florida, United States
Breelyn A. Wilky, MD (she/her/hers)
Associate Professor
University of Colorado Cancer Center
Aurora, Colorado, United States
Melissa A. Burgess, MD (she/her/hers)
-
University of Pittsburgh Medical Center Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Arun Singh, MD (he/him/his)
Associate Professor
University of California Los Angeles
Santa monica, California, United States
Steven Attia, D.O.
Consultant
Mayo Clinic
Jacksonville, Florida, United States
Mark Agulnik, MD (he/him/his)
Sarcoma Section Chief
City of Hope, Department of Medical Oncology & Therapeutics Research
Duarte, California, United States
William D. Tap, MD
Chief, Sarcoma Medical Oncology
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Sebastian Bauer, MD (he/him/his)
Attending, Director Sarcoma Center
Department of Medical Oncology, West German Cancer Center, University Hospital Essen
Essen, Nordrhein-Westfalen, Germany
Robin L. Jones, BSc, MB BS, MRCP, MD
Consultant Medical Oncologist
Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
London, England, United Kingdom
César Serrano, MD, PhD
Medical Oncology Department, Hospital Universitario Vall d'Hebron, Vall d'Hebron Institute of Oncology, Barcelona, Spain
Barcelona, Catalonia, Spain
Liangxing Zou, PhD
Cogent Biosciences
Waltham, Massachusetts, United States
Kevin Moynihan
Director, Clinical Operations
Cogent Biosciences
Waltham, Massachusetts, United States
Julia Lawrence, DO
Senior Medical Director, Clinical Sciences
Cogent Biosciences
Waltham, Massachusetts, United States
Andrew J. Wagner, MD, PhD
Associate Professor of Medicine
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
